Literature DB >> 2380801

Excess insured health care costs from tobacco-using employees in a large group plan.

M Penner1, S Penner.   

Abstract

Health insurance costs from tobacco have been estimated from tobacco's contribution to annual or lifetime costs for heart disease, emphysema, and selected cancers. Because health plans seldom identify tobacco users, there are few published studies that compare users with nonusers. This study gathered data on paid claims from a large group's indemnity plan (4108 users, 16,723 nonusers) from Jan 1 to Nov 30, 1988. Tobacco users had more admissions per 1000 (124 v 76), days per 1000 (800 v 381), a longer average length of stay (6.47 v 5.03 days), higher average outpatient payments ($122 v $75), and higher average insured payments ($1,145 v $762). Tobacco use is correlated with other high-risk behaviors; thus, cost and utilization differences are not solely due to its effects. Nevertheless, tobacco users add to employer costs for health insurance as well as for absenteeism, workers' compensation, and life insurance. Employers may use these data to reduce costs by not hiring tobacco users, adding surcharges for their health insurance, and strongly encouraging cessation. Issues of equity are discussed in terms of coerciveness and intrusiveness.

Entities:  

Mesh:

Year:  1990        PMID: 2380801     DOI: 10.1097/00043764-199006000-00008

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  3 in total

1.  Occupational risks associated with cigarette smoking: a prospective study.

Authors:  J Ryan; C Zwerling; E J Orav
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

2.  Short term effects of cigarette smoking on hospitalisation and associated lost workdays in a young healthy population.

Authors:  A S Robbins; V P Fonseca; S Y Chao; G A Coil; N S Bell; P J Amoroso
Journal:  Tob Control       Date:  2000-12       Impact factor: 7.552

3.  Health and social costs of tobacco use in Ontario, Canada, 1979 and 1988.

Authors:  B C Choi; A W Pak
Journal:  J Epidemiol Community Health       Date:  1996-02       Impact factor: 3.710

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.